Welcome to the Center For Advanced Metabolic Imaging in Precision Medicine (CAMIPM)
The CAMIPM will develop and translate cutting edge noninvasive metabolic imaging biomarkers for use in biomedical research. Technology development is focused in four major application areas: Oncology, Cardiovascular disease, Neuropsychiatry, and Musculoskeletal disorders. These technologies will have substantial impact on the fundamental understanding of disease mechanisms, early diagnosis, and development of novel therapies for several diseases such as Alzheimer’s disease, Epilepsy, Arthritis, Cancer, Stroke, and heart disease, and thus contribute to precision medicine and enhanced patient care. The facility’s core sections provide research and computing resources for numerous user, collaborative, and training projects.
The focus of this center is on developing instrumentation, methodologies, and data analysis techniques for the quantitative assessment of functional, structural, and metabolic parameters in humans with the use of chemical exchange weighted molecular magnetic resonance imaging (MRI), MRI of oxygen consumption, down field spectroscopy, and diffuse optical imaging techniques.